tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
Company AnnouncementsHansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
22h ago
3692
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
PremiumCompany Announcements
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
22h ago
3692
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
PremiumCompany Announcements
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
22h ago
3692
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
PremiumCompany Announcements
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
2d ago
3692
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
PremiumCompany Announcements
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
2d ago
3692
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
PremiumCompany AnnouncementsHansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
2d ago
3692
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
Premium
Company Announcements
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
14d ago
3692
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
Premium
Company Announcements
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
1M ago
3692
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
1M ago
3692
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
PremiumCompany Announcements
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
1M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
1M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
1M ago
3692
Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany AnnouncementsHansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
1M ago
3692
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
Premium
Company Announcements
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
2M ago
3692
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
Premium
Company Announcements
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
2M ago
3692
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
PremiumCompany Announcements
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
3M ago
3692
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
PremiumCompany Announcements
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
3M ago
3692
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
PremiumCompany Announcements
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
4M ago
3692
Hansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
PremiumCompany Announcements
Hansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
4M ago
3692
Hansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
PremiumCompany AnnouncementsHansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
4M ago
3692
Hansoh Pharmaceutical Details Board Composition and Committee Roles
Premium
Company Announcements
Hansoh Pharmaceutical Details Board Composition and Committee Roles
4M ago
3692
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
Premium
Company Announcements
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
5M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >